Nicolas C. Andre

Sanary Sur Mer, 83110, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 204 publications

Correction: Conditional generation of free radicals by selective activation of alkoxyamines: towards more effective and less toxic targeting of brain tumors.

Correction: Conditional generation of free radicals by selective activation of alkoxyamines: towards more effective and less toxic targeting of brain tumors.

Journal: Chemical science

Published: June 10, 2026

Correction: Phase I/II, open-label, multicenter study of durvalumab in combination with tremelimumab in pediatric patients with advanced solid tumors.

Correction: Phase I/II, open-label, multicenter study of durvalumab in combination with tremelimumab in pediatric patients with advanced solid tumors.

Journal: Frontiers in oncology

Published: May 20, 2026

Precision neuro-oncology for children: Time to gear up!

Precision neuro-oncology for children: Time to gear up!

Journal: Trends in cancer

Published: April 02, 2026

Building a new arsenal: repurposed drugs and metronomic chemotherapy against medulloblastoma.

Building a new arsenal: repurposed drugs and metronomic chemotherapy against medulloblastoma.

Journal: Expert review of neurotherapeutics

Published: February 18, 2026

From Diagnosis Delay to Targeted Therapy: A Retrospective Study of Pediatric DLGNT with a Comprehensive Literature Review.

From Diagnosis Delay to Targeted Therapy: A Retrospective Study of Pediatric DLGNT with a Comprehensive Literature Review.

Journal: Cancers

Published: December 31, 2025

Dabrafenib in pediatric patients with BRAF V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm study.

Dabrafenib in pediatric patients with BRAF V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm study.

Journal: Neuro-oncology practice

Published: December 29, 2025

Paediatric therapeutic development workshop on medulloblastoma.

Paediatric therapeutic development workshop on medulloblastoma.

Journal: British journal of cancer

Published: December 13, 2025

Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART Trial.

Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART Trial.

Journal: Targeted oncology

Published: November 24, 2025

Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 08, 2025

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 07, 2025

Near Complete Response With Trastuzumab Deruxtecan in a Teenager With Relapsing Metastatic Desmoplastic Small Round Cell Tumor.

Near Complete Response With Trastuzumab Deruxtecan in a Teenager With Relapsing Metastatic Desmoplastic Small Round Cell Tumor.

Journal: Pediatric blood & cancer

Published: August 08, 2025

Phase I/II, open-label, multicenter study of durvalumab in combination with tremelimumab in pediatric patients with advanced solid tumors.

Phase I/II, open-label, multicenter study of durvalumab in combination with tremelimumab in pediatric patients with advanced solid tumors.

Journal: Frontiers in oncology

Published: August 05, 2025

Showing 1-12 of 204

Last Updated: 09/26/2026